ClinicalTrials.Veeva

Menu

Salvage Brachytherapy and Hyperthermia for Recurrent H&N-tumours (HyBT-H&N)

U

University of Erlangen-Nürnberg Medical School

Status

Enrolling

Conditions

Locally Recurrent Head and Neck Cancer

Treatments

Other: Hyperthermia
Radiation: Brachytherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT03238378
HyBT-H&N

Details and patient eligibility

About

The aim of the present trial is to assess the prospective results of protocol-based interstitial pulsed-dose-rate (PDR) brachytherapy with interstitial hyperthermia (iHT) in a group of selected patients where salvage surgery with clear resection margins was not possible.

Enrollment

96 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Histologically confirmed recurrent carcinoma of the head and neck region
  • Stage rcT1-3
  • Tumor anatomy and location suitable for brachytherapy techniques.
  • cN0/pN0 or rpN+ & R0 with <3 pos. LND & without invasion of capsula.
  • M0
  • ECOG 0-2
  • Previous radiation therapy up to at least 50 Gy
  • Previous radiation therapy completed more than 6 months ago
  • Written study-specific informed consent

Exclusion criteria

  • cT4
  • rpN+ with >2 pos. LND or invasion of capsula
  • Pregnant or lactating women
  • Collagen vascular disease
  • The presence of congenital diseases with increased radiation sensitivity, for example Ataxia telangiectatica or similar
  • Psychiatric disorders

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

96 participants in 1 patient group

Therapy
Experimental group
Description:
Brachytherapy d1-5(6) Hyperthermia d2 + 5
Treatment:
Other: Hyperthermia
Radiation: Brachytherapy

Trial contacts and locations

1

Loading...

Central trial contact

Vratislav Strnad, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems